- CA$1.07bn
- CA$927.34m
- CA$130.18m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 204 | 129 | 178 | 421 | 130 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 32 | 31.6 | 64.4 | 41 | 56.7 |
Operating Profit | 172 | 97.7 | 113 | 380 | 73.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 138 | 79.3 | 117 | 375 | 63.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 119 | 69.5 | 105 | 330 | 52.4 |
Net Income Before Extraordinary Items | |||||
Net Income | 119 | 69.5 | 105 | 330 | 52.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 119 | 69.5 | 105 | 330 | 52.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.87 | 4.6 | 6.96 | 21.9 | 3.48 |
Dividends per Share | |||||
Special Dividends per Share |